Recap of KND 2017

Presentations from Knowledge & Network Day for you to review and share. Videos are being added on an on-going basis, so check back often!

Take a look at the presentations from four parallel tracks offering practical knowledge from subject matter experts, cases from global Life Science companies, and new technology information from suppliers. See the individual presentations by clicking on the track title. 

DK K N Agenda Landing Page Header 1

Thank you to these companies

Keynote: The Future of Life Science is Digital

The Future of Life Science is Digital
Klavs Esbjerg, CEO and Founder, Epista Life Science

Life Science companies are constantly bombarded with new regulations, new technology and new business initiatives. They must find the optimal balance between risk and efficiency so that regulatory compliance does not stand in the way of digitalization, analytics, patient-centricity, and more. 

We hear serious questions from the industry:
- Are we overspending on time and resources, hampering efficiency and our bottom line?
- Are we underspending and running the risk of our compliance getting out-of-control?

This presentation offered insights into this challenge, including concrete actions to help your company balance compliance efforts between risk and efficiency. Finding the optimal balance between these two extremes is critical, for it is here that compliance moves from being an obstacle into actually helping your company achieve your business goals.

Data Track

Moderator: Rasmus Torp Kristensen, Team Manager, Epista Life Science

To reach the digital future, companies must become data-driven. Your data must be accessible, controlled, and secure. But in many companies, data is still scattered and inconsistent. Join the Data Track to hear the hot topics around data in the digital future. We tackled common problems, offered insight and solutions, and gave a regulatory perspective on data. 

Presentation 1: System-Centric to Data-Driven: Move from dark data into data that provides insight and value
Morten Friis, Principal Consultant, Epista Life Science

Companies need to move from a system-centric approach to a data-driven one. Join this presentation to explore exactly what this means. Where are we now? Where are we going? What can we do differently in the future when we implement new systems? How can we structure our data to get more insight?

Presentation 2: Content Migration & Beyond
Jason Mitrow, Senior Technology Strategist, Adlib

Presentation 3: Data Integrity from a Regulatory Perspective
Ib Alstrup, IT Medicines Inspector, Danish Medicines Agency

Join Ib Alstrup as he explores the expectations of the Danish Medicines Agency to procedures and functionality ensuring Data Integrity in regulated GMP/GDP environments. Don't miss this insight into a regulator's view of a Data Integrity inspection.

Presentation 4: Data Integrity - A Practical Perspective
Keith Williams, Member of ISPE GAMP European Committee
VIDEO: Keith Williams Gives a Brief Intro to Data Integrity - A Practical Perspective

Dive into data in the real world. What can and should we do - instead of what are all possible things we might do? Keith discussed examples from manufacturing and labs, highlighting the differences in requirements of data integrity between GMP and GLP environments.

Advanced IT Compliance Track

Moderator: Lars Moltke Hansen, Senior Consultant, Epista Life Science

Compliance is becoming increasingly complex, with ever changing requirements and new technology constantly creating challenges. How do you stay in control on the way to the digital future? We covered major developments in IT compliance focusing on practical information that you can use to add value when you get back to your office. 

Presentation 1: CASE: Spot-on compliance – Finding the right balance between compliance and risk
Hanne Harbo Hansen, Principal Consultant, Epista Life Science
VIDEO: Introduction to Benchmarking Compliance from Hanne

Get the story of a Medical Device organization that turned a benchmarking exercise into a visual risk-based management tool. They aligned quality objectives across QA and operations. The focus was quality, and the result was efficiency. Learn exactly how they did it. 

Presentation 2: What's next for the cloud?
Jonathan Burd, Strategy Director - Vault Quality Europe, Veeva 
VIDEO: Jonathan Burd gives a Strategic Overview of Cloud 2.0

A significant number of life science organizations have now embraced cloud applications and are seeing greater compliance, improved quality, and reduced operational overhead. But, what’s next for the cloud? In this session, Jonathan Burd explored how the cloud might evolve in future and its impact on IT complience and quality management. What are the possible directions that cloud development may take and what opportunities might be available as the cloud moves to the next level? 

Presentation 3: Practical experience of a Life Science cloud customer
Susanne Kiehn, Principal Consultant, Epista Life Science

Learn from Susanne's experience with cloud solutions for more than 10 years in the Life Science industry. She shared what she's learned from facing the practical challenges of staying in control, even while 'going cloud', in a regulated environment. 

Presentation 4: CASE - Data Privacy (GDPR) in Radiometer
Mikael Yde, IT Compliance Officer, Data Privacy Lead, Radiometer Medical

Hear how the upcoming General Data Protection Regulation (GDPR) was received and is being dealt with in a Medical Device organization. The stumbling startup, gaining understanding and organizational awareness, becoming part of a global Data Privacy program, the interference of two FDA inspections and the current progress of implementation activities.

Serialization Track

Moderator: Christian Holse, Senior Consultant, Epista Life Science

Many companies are, by now, in the final stages of implementing their serialization program. These stages are crucial to the overall success of the projects, not only to optimize the processes and ensure smooth onboarding, but also to create a program that enhances your business. How can we ensure that serialization is actually supporting business goals? We discussed turning serialization into an asset through digitalization, data management, and other strategies to create value beyond compliance. 

Presentation 1: CMO-MAH integration challenges and success factors for timely compliance
Stanley Samuel, Group Manager - EMEA (CMO/3PL), TraceLink

TraceLink's early project experience/learning with the top 30 pharma companies is that more than 50% of them have complex integration requirements due to the legacy ERP solutions in place. Even though GS1 standards such as EPCIS aim to standardize data exchange, there are still 3 versions to adhere to: EPCIS v1.0, 1.1 and 1.2. By integrating once and interoperating with your partner ecosystem, you can address the complexity of data exchange in a compliant, validated fashion. Learning how to do this will save you time and cost on an already expensive serialization project. 

Presentation 2: Beyond Compliance - The Digital Future and IoT
Dr. Aytac Atac, Director of Digital Innovation, Supply Chain Wizard

The Pharma industry is going through a large scale transformation with serialization projects. Is serialization just a project we need to perform to comply to regulations? Or can we get real business value out of the ongoing track & trace programs and create sustainable improvement at the supply chain? Driven by the track & trace requirements, at Supply Chain Wizard, we place innovation at the core of our projects to make positive impact to the day-to-day business operations of our clients while complying to the regulations. We presented the real life client case examples in digital transformation of factories and pharma supply chains.   

Presentation 4: OnDemand Workflow - Flow 24 & Panel Discussion
OnDemand Workflow - Flow 24Jesper Holm, Owner, Graphic West
Stanley Samuel, Group Manager - EMEA (CMO / 3PL), TraceLink
Evren Ozkaya, Founder and CEO, Supply Chain Wizard
Henrik Egede Hansen, Validation Lead at Novo Nordisk

Medical Device Track

Moderator: Karin Grostøl Nielsen, Principal Consultant, Epista Life Science

New medical device technology is driving the industry forward toward patient-centricity, value beyond the pill/device, and insightful new sources of data that can improve health and patient outcomes. However, with these advances comes increased attention and pressure from regulatory authorities, who have set newly high demands for Medical Device companies. How can we bridge the gap between rapidly advancing technology and regulatory requirements? In this track, we covered audits, apps, and new regulations, with the goal in mind of turning compliance efforts into business assets. 

Presentation 1: CASE - Succeeding with Back-to-Back FDA Inspections
Lena Munk Sørensen, Vice President QA/RA, Radiometer Medical

Hear from Radiometer about how they prepared for and successfully executed their recent FDA inspections. Learn from their experience so you don’t have to reinvent the wheel.

Presentation 2: UDI Compliance in EU
Jesper Kervin Franke, Healthcare Manager, GS1

Jesper will go beyond UDI basics. He'll explore UDI requirements around the world, drilling down into the EU requirements. And for a practical angle, he'll discuss how to use GS1 standards to become UDI compliant for the EU. You'll have a chance to ask specific questions about your own UDI challenges.

Presentation 3: Mobile Technology in Clinical Trials
Helene Kiil, IT Quality Specialist, Novo Nordisk

Join us to discuss the use of mobile technology in clinical trials and explore how Life Science companies and technology providers can work together to harvest the benefits while ensuring compliance.

Presentation 4: MDR & IVDR from the regulator's perspective
Thomas Wejs Møller, Section Manager for Medical Devices, Danish Medicines Agency - Lægemiddelstyrelsen